Tecentriqnew

802,52 

Therapeutic PD-L1-antibody from the original commercial drug Tecentriq targeting the PD-L1-antigen, also referred to as Atezolizumab antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Manufacturing Year Expiry date Availability Certificate of Analysis (CoA) PriceQuantityTotal
aliquot 6020012B0006B01201803/20224 wksYes 802,52 
-
+
802,52 
spinner

Category: SKU: N/A

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Atezolizumab

Antigen

PD-L1

Product Concentration [mg/mL]

60

Volume per Vial [µL]

200

Quantity per vial [mg]

12

Batch Number

NOT SPECIFIED, B0006B01

Manufacturing Year

-, 2018

Expiry date

03/2022

Availability

4 wks

Certificate of Analysis (CoA)

Yes, No

You may also like…